Publication:
Donor-derived cell-free DNA in acute and chronic rejection of solid allograft transplantation

Simple item page
dc.contributor.authorMuro-Pérez, Javier
dc.contributor.authorMuro-Pérez, Manuel
dc.contributor.authorGalián, José Antonio
dc.contributor.authorPérez- López, Noelia
dc.contributor.authorLegaz Pérez, Isabel
dc.contributor.authorMuro, Manuel
dc.contributor.departmentCiencias Sociosanitarias
dc.contributor.otherFacultad de Química
dc.date.accessioned2026-05-13T05:56:42Z
dc.date.available2026-05-13T05:56:42Z
dc.date.copyright© 2026 The Author(s), under exclusive license to Springer Nature Switzerland AG
dc.date.issued2026-01-02
dc.description.abstractToday, there have been spectacular advances in surgical techniques, organ preservation for transplantation, optimal and efficient donor and recipient selection, more efficient diagnosis of transplant complications, and major progress in pharmacological immunosuppression procedures. In this regard, survival rates after transplantation of various organs have been gaining ground, particularly in the case of lung transplants, whose average survival rate is lower than other types of transplants. In this regard, it is important to detect acute and subclinical clinical rejection, as well as chronic allograft rejection. This is especially important in heart and lung transplants. In the latter type of transplant, and due to the chronic dysfunction of the lung allograft, it is key to detect rejection early and promptly, as it can affect up to half of the transplant patient population. Therefore, effective diagnostic tools are needed to visualize the level of allograft damage using genomic methods such as those that measure donor-derived cell-free DNA (dd-cfDNA). The plasma concentration of dd-cfDNA increases after graft injury or infection. Our team has experience quantifying this parameter in allograft injury progression, and our experience and comparison with the published literature will be presented in the following sections, discussing validated and non-validated results.
dc.formatapplication/pdf
dc.format.extent14
dc.identifier.doihttps://doi.org/10.1007/978-3-032-07686-1_7
dc.identifier.eisbn978-3-032-07686-1
dc.identifier.isbn978-3-032-07685-4
dc.identifier.urihttp://hdl.handle.net/10201/231581
dc.languageeng
dc.publisherSpringer
dc.relationSupport from “Fundación Mutua Madriñeña” Fund. Nª Project: AP183152023
dc.relation.ispartofCellular and molecular mechanism of chronic rejection in organ transplantation. Ed.: Springer, pp. 151-164
dc.relation.publisherversionhttps://link.springer.com/chapter/10.1007/978-3-032-07686-1_7
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectGraft rejection
dc.subjectOrgan transplantation
dc.subjectTolerance
dc.subjectBiomarker
dc.subjectDd-cfDNA
dc.subject.odsNo relacionado con ningún objetivo de desarrollo sostenible
dc.titleDonor-derived cell-free DNA in acute and chronic rejection of solid allograft transplantation
dc.typeinfo:eu-repo/semantics/bookPart
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublicationes
relation.isAuthorOfPublicationb83b4b59-2d61-40f0-9108-5c6a6d158295
relation.isAuthorOfPublication.latestForDiscoveryb83b4b59-2d61-40f0-9108-5c6a6d158295
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Capitulo Springer_Legaz I 2026.pdf
Size:
1.51 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.37 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Libros o capítulos de libro